查詢結果分析
相關文獻
- Clinical Efficacy of Recombinant Human Erythropoietin in the Treatment of Anemia in Hemodialysis Patients: Influence of Dosing Regimen, Iron Status, and Serum Aluminum
- Effect of Rocombinant Human Erythropoietin in Severe Anemic and Iron- Dverloaded Patients on Maintenance Hemodialysis
- Serum Transferrin Receptor Concentration is Not Indicative of Erythropoietic Activity in Chronic Hemodialysis Patients with Poor Response to Recombinant Human Erythropoietin
- 長期血液透析尿毒症病患接受低劑量紅血球生成素治療的血壓及生化值變化
- Treatment of the Anemia of Chronic Hemodialysis Patients with Recombinant Human Erythropoietin
- 尿毒症貧血治療的新趨勢﹣﹣基因合成人類生紅血球素之治療原則
- The Effect of Subcutaneous r-HuEPO in Cancer Patients Receiving Chemotherapy with Anemia: A Preliminary Report
- Low Dose Intravenous Ascorbic ACID for Erythropoietin-Hyporesponsive Anemia in Hemodialysis Patients with Iron Overload
- Human Recombinant Erythropoietin and Phlebotomy in the Treatment of Iron Overload in Uremic Patients
- 基因重組合成性人類紅血球生成素之臨床應用
頁籤選單縮合
題 名 | Clinical Efficacy of Recombinant Human Erythropoietin in the Treatment of Anemia in Hemodialysis Patients: Influence of Dosing Regimen, Iron Status, and Serum Aluminum=基因合成人類生紅血球素治療血液透析病人貧血之臨床效果: 給予方法, 鐵含量狀態, 和血清鋁濃度對治療反應之影響 |
---|---|
作 者 | 蔡哲嘉; | 書刊名 | 高雄醫學科學雜誌 |
卷 期 | 7:3 1991.03[民80.03] |
頁 次 | 頁126-135 |
分類號 | 414.81 |
關鍵詞 | 人類; 反應; 方法; 生; 合成; 血液透析; 血清; 含量; 治療; 狀態; 紅血球; 效果; 病人; 基因; 貧血; 給予; 影響; 鋁; 濃度; 臨床; 鐵; |
語 文 | 英文(English) |